You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Disruptive Technologies in BioPharma

Disruptive Technologies in an Ever-Evolving BioPharma Environment

Kevin Smyth, Global Director of Process Technology with IPS, spoke at the two-day virtual ACHEMA Pulse Conference with the topic of Disruptive Technologies in the BioPharmaceutical Sector. This virtual showcase is on several disruptive technologies and innovations that regulators are now actively encouraging in the life science sector to assess and implement.

  • A Disruptive Technology is one that displaces an established technology and shakes up the industry or a ground-breaking product that creates a completely new industry.  
  • A Disruptive Innovation is the introduction of a product or service into an established industry that performs better and, generally, at a lower cost than existing offerings, thereby displacing the market leaders in that particular market space and transforming the industry.

Related Experts


Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.


We use cookies to personalize and enhance your experience on our site. Visit our Privacy Policy to learn more.